Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Fundam Clin Pharmacol ; 32(5): 507-515, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29577374

RESUMO

Epoxy-carvone (EC) has chiral centers that allow generation of stereoisomers, including (+)-cis-EC and (-)-cis-EC, whose effects in the kindling tests have never been studied. Accordingly, this study aims to comparatively investigate the effect of stereoisomers (+)-cis-epoxy-carvone and (-)-cis-epoxy-carvone on behavioral changes measured in scores, in the levels of cytokines (IL-1ß, IL-6, and TNFα) and neuronal protection in the face of continuous treatment with pentylenetetrazol. Swiss mice were divided into five groups (n = 10), receiving vehicle, (+) - cis-EC, (-) - cis-EC (both at the dose of 30 mg/kg), and diazepam (4 mg/kg). Thirty minutes after the respective treatment was administered to the animals one subconvulsive dose of PTZ (35 mg/kg). Seven subconvulsives treatments were made on alternate days, in which each treatment several parameters were recorded. In the eighth treatment, the animals receiving the highest dose of PTZ (75 mg/kg) and were sacrificed for quantification of cytokines and histopathologic analysis. All drugs were administered by intraperitoneal route. In the kindling test, (+)-cis-EC and (-)-cis-EC reduced the average scores. The stereoisomer (+)-cis-EC decreased levels of proinflammatory cytokines IL-1ß, IL-6, and TNFα, whereas comparatively (-)-cis-EC did not reduce IL-1ß levels. Histopathological analysis of the mice hippocampi undergoing this methodology showed neural protection for treated with (+)-cis-EC. The results suggest that the anticonvulsant effect of (+)-cis-EC possibly takes place due to reduction of proinflammatory cytokines involved in the epileptogenic process, besides neuronal protection, yet further investigation of the mechanisms involved is required.


Assuntos
Anticonvulsivantes/farmacologia , Excitação Neurológica/efeitos dos fármacos , Monoterpenos/farmacologia , Neuroproteção/efeitos dos fármacos , Animais , Anticonvulsivantes/química , Comportamento Animal/efeitos dos fármacos , Monoterpenos Cicloexânicos , Citocinas/efeitos dos fármacos , Camundongos , Monoterpenos/química , Pentilenotetrazol/farmacologia , Estereoisomerismo
2.
Naunyn Schmiedebergs Arch Pharmacol ; 390(9): 863-869, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28577050

RESUMO

(1S)-(-)-verbenone (VRB) is a monoterpene present in the essential oils of many plants which has shown therapeutic effect; however, its anticonvulsant activity has not yet been evaluated. The present work sought to investigate the anticonvulsant activity of VRB using pilocarpine and pentylenetetrazole-induced seizure testing; seeking also probable mechanisms of action. VRB caused no significant changes in motor coordination. Also, no significant data was observed in the pilocarpine-induced seizure tests. In the PTZ-induced seizures test, VRB showed anticonvulsant activity at doses of 200 mg/kg i.p. (733 ± 109.4 s) and 250 mg/kg i.p. (648.8 ± 124.5 s) significantly increasing the latency to onset of first seizure as compared with the vehicle group (51.8 ± 2.84 s). Pretreatment with flumazenil (FLU) did not reverse the anticonvulsive effect of VRB; however, it was able to upregulate BDNF and COX-2 genes and downregulate c-fos. The findings suggest that the anticonvulsant effects of VRB may be related to RNA expression modulations of COX-2, BDNF, and c-fos.


Assuntos
Anticonvulsivantes/farmacologia , Convulsões/tratamento farmacológico , Terpenos/farmacologia , Animais , Anticonvulsivantes/administração & dosagem , Monoterpenos Bicíclicos , Fator Neurotrófico Derivado do Encéfalo/genética , Ciclo-Oxigenase 2/genética , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Regulação para Baixo/efeitos dos fármacos , Masculino , Camundongos , Pentilenotetrazol , Pilocarpina , Proteínas Proto-Oncogênicas c-fos/genética , RNA Mensageiro/metabolismo , Terpenos/administração & dosagem , Regulação para Cima/efeitos dos fármacos
3.
Molecules ; 20(11): 19660-73, 2015 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-26528962

RESUMO

Stereoisomers of the monoterpene epoxycarvone (EC), namely (+)-cis-EC, (-)-cis-EC, (+)-trans-EC, and (-)-trans-EC, were comparatively evaluated for anticonvulsant activity in specific methodologies. In the pentylenetetrazole (PTZ)-induced anticonvulsant test, all of the stereoisomers (at 300 mg/kg) increased the latency to seizure onset, and afforded 100% protection against the death of the animals. In the maximal electroshock-induced seizures (MES) test, prevention of tonic seizures was also verified for all of the isomers tested. However, the isomeric forms (+) and (-)-trans-EC showed 25% and 12.5% inhibition of convulsions, respectively. In the pilocarpine-induced seizures test, all stereoisomers demonstrated an anticonvulsant profile, yet the stereoisomers (+) and (-)-trans-EC (at 300 mg/kg) showed a more pronounced effect. A strychnine-induced anticonvulsant test was performed, and none of the stereoisomers significantly increased the latency to onset of convulsions; the stereoisomers probably do not act in this pathway. However, the stereoisomers (+)-cis-EC and (+)-trans-EC greatly increased the latency to death of the animals, thus presenting some protection. The four EC stereoisomers show promise for anticonvulsant activity, an effect emphasized in the isomers (+)-cis-EC, (+)-trans-EC, and (-)-trans-EC for certain parameters of the tested methodologies. These results serve as support for further research and development of antiepileptic drugs from monoterpenes.


Assuntos
Anticonvulsivantes/química , Monoterpenos/química , Animais , Monoterpenos Cicloexânicos , Eletrochoque/efeitos adversos , Masculino , Camundongos , Estrutura Molecular , Pentilenotetrazol/efeitos adversos , Convulsões/diagnóstico , Convulsões/tratamento farmacológico , Convulsões/etiologia , Estereoisomerismo , Estricnina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA